NOT Profitability Analysis: Margins, Return on Capital, Free Cash Flow, and More - Novartis AG

Watchlist Manager

Watchlist

Price: 80.16 EUR -0.27% Market Closed

Market Cap: €182.3B

	Novartis AG F:NOT	CH
L	LyondellBasell Industries NV LSE:0EDD	UK
J	Japan Tobacco Inc XMUN:JAT	JP
A	Abeona Therapeutics Inc F:PCJP	US
H	Henry Schein Inc F:HS2	US
F	Fennec Pharmaceuticals Inc NASDAQ:FENC	US
E	Exelon Corp BMV:EXC	US
	New China Life Insurance Co Ltd F:NCL	CN
3	3U Holding AG DUS:UUU	DE
H	Home Depot Inc F:HDI	US
	Lynas Rare Earths Ltd ASX:LYC	MY

Profitability Summary

Novartis AG's profitability score is Hidden . We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.

Exceptional Gross Margin

75%

Strong 3Y Average Gross Margin

75%

Gross Margin is Increasing

73% > 75%

Exceptional Operating Margin

32%

Sustainable 3Y Average Operating Margin

29%

Operating Margin is Increasing

23% > 32%

Healthy Net Margin

24%

Sustainable 3Y Average Net Margin

26%

Net Margin is Increasing

17% > 24%

Exceptional Free Cash Flow Margin

28%

Strong 3Y Average Free Cash Flow Margin

27%

Free Cash Flow Margin is Increasing

24% > 28%

Exceptional ROE

35%

Exceptional 3Y Average ROE

Positive 3Y Average ROIC

15%

ROIC is Increasing

11% > 16%

View All Checks

We take all the information about a company's profitability, such as its margins, capital efficiency, free cash flow generating ability, and more, and consolidate it into one single number: the profitability score. The higher the profitability score, the more profitable the company is.